Anzeige
Mehr »
Montag, 30.03.2026 - Börsentäglich über 12.000 News
Globaler Roll-out startet: Explosives Update: CA$8,4 Mio. Auftragsbestand - Nexus rollt Europa & Arktis auf
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Alliance News

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
FrGreenRoc shares rise as enters license deal for coating technology
FrSwitch Metals stock falls but Issia Project's first MRE draws closer
FrWINNERS & LOSERS: Publisher Future down after Jefferies downgrade
FrPensana first-half loss widens, remains upbeat on rare earth market
FrIN BRIEF: Petards subsidiary QRO Solutions wins two contracts
FrCT Private Equity Trust ups dividend as net asset value rises
FrIN BRIEF: Shaftesbury Capital Chair Jonathan Nicholls sells shares
FrWINNERS & LOSERS: Metlen Energy takes hit from annual results delay
FrRoquefort springs over to AIM from Main Market as Coiled Therapeutics
FrGB Group refinances GBP175 million revolving credit facility
FrIN BRIEF: Jardine Matheson CEO buy further USD750,000 in shares
FrIN BRIEF: Hargreaves Services increases tender offer to GBP20 million
FrHerald Investment eyes backstop tender, other alternatives to Saba
FrIN BRIEF: Playtech starts GBP19 million share buyback
FrLONDON BROKER RATINGS: BofA raises Berkeley; UBS raises Savills
FrIran holding world's economy "hostage" with Hormuz closure - Cooper
FrSenior agrees to extend Advent takeover offer deadline amid talks
FrIN BRIEF: Avacta raises GBP10 million in equity for clinical tests
FrNearly half a million Lloyds customers hit by data breach after glitch
FrLONDON MARKET OPEN: Stocks mixed as Brent oil nears USD110
FrBASF lowers stake in Harbour Energy to 35% after upsized placing
FrEuropean Medicine Agency to review GSK's chronic hepatitis B treatment
FrAstraZeneca hails positive results in tozorakimab lung disease trials
FrIN BRIEF: Metlen delays release of 2025 results to complete audit
FrLONDON BRIEFING: UK retail sales fall; GSK drug accepted for review